Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

The development of brain metastases (BMs) in breast cancer (BC) patients remains a challenging complication. Current clinical practice guidelines recommend local treatment of BMs without changing systemic therapy (CST) in patients with stable extracranial disease. We retrospectively investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhalabi, Omar, Soomro, Zaid, Sun, Ryan, Hasanov, Elshad, Albittar, Aya, Tripathy, Debu, Valero, Vicente, Ibrahim, Nuhad K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979865/
https://www.ncbi.nlm.nih.gov/pubmed/33742001
http://dx.doi.org/10.1038/s41523-021-00235-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979865/
https://www.ncbi.nlm.nih.gov/pubmed/33742001
http://dx.doi.org/10.1038/s41523-021-00235-7

Ejemplares similares